Santaris Pharma

Developer of RNA-targeted therapies for infectious and metabolic diseases

placeCopenhagen, Capital Region Of Denmark, Denmark calendar_todayFounded 2003 groups60 employees language santaris.com

Registered entities

Innovation

109 patent families (45 granted) — focus: Chemistry & metallurgy, Human necessities, Emerging technologies, Physics & computing; filing pace slowing. Cited 9,556 times.

YearFilings
201238
201334
201432
201514
20168
20179
20185
20196
20202
20212
20221

Investor mix

17 investors on record; lead investors include Pfizer, Forbion, Seventure Partners, Sunstone; 3 have since exited.

Investor typeCountShare
Venture capital953%
Private equity212%
Bank & private debt16%
Other / undisclosed529%
Coming soon